Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel Plus Gemcitabine and Cisplatin in Urothelial Cancer
NCT02560038Phase 2Terminated
- Sponsor
- UTHealth Houston
- Start
- Oct 2015
- Primary completion
- Sep 2017
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection in urothelial carcinoma (UC), sponsored by UTHealth Houston. Started Oct 2015; status: terminated.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT02560038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02560038.